Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH realizes net loss of $0.40 million in Q1 2016


According to Jerusalem Pharmaceuticals financial statements for 1st Quarter of 2016, Net Loss after tax of the period reached (398,776) USD Compared with Net profit after tax 896,208 USD for 2015.Total assets of the company reached 51,422,421 USD compared with total assets of 51,192,232 USD at the end of year 2015, a net increase of 0.45%.Total liabilities of the company reached 14,900,539 USD compared with total liabilities of 14,983,341 USD at the end of year 2015, a net decrease of 0.55%. Net ownership equity of the company reached 36,521,882 USD (Including None-Controlling Interests of 546,977 USD) compared with total owner equity of 36,208,891 USD (Including None-Controlling Interests of 647,664 USD) at the end of year 2015, a net increase of 0.86%.


Al-Quds Index in a narrow range with the approaching end of 2022

The PEX records average PE of 12.4x and average P/BV of 1.51x in 9M 2022



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013